Moores KE

References (2)

Title : The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2 - Blackie_2003_Bioorg.Med.Chem.Lett_13_1067
Author(s) : Blackie JA , Bloomer JC , Brown MJ , Cheng HY , Hammond B , Hickey DM , Ife RJ , Leach CA , Lewis VA , Macphee CH , Milliner KJ , Moores KE , Pinto IL , Smith SA , Stansfield IG , Stanway SJ , Taylor MA , Theobald CJ
Ref : Bioorganic & Medicinal Chemistry Lett , 13 :1067 , 2003
Abstract : Blackie_2003_Bioorg.Med.Chem.Lett_13_1067
ESTHER : Blackie_2003_Bioorg.Med.Chem.Lett_13_1067
PubMedSearch : Blackie_2003_Bioorg.Med.Chem.Lett_13_1067
PubMedID: 12643913

Title : Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor - MacPhee_1999_Biochem.J_338 ( Pt 2)_479
Author(s) : Macphee CH , Moores KE , Boyd HF , Dhanak D , Ife RJ , Leach CA , Leake DS , Milliner KJ , Patterson RA , Suckling KE , Tew DG , Hickey DM
Ref : Biochemical Journal , 338 ( Pt 2) :479 , 1999
Abstract : MacPhee_1999_Biochem.J_338 ( Pt 2)_479
ESTHER : MacPhee_1999_Biochem.J_338 ( Pt 2)_479
PubMedSearch : MacPhee_1999_Biochem.J_338 ( Pt 2)_479
PubMedID: 10024526